Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Surgical Resection of Superficial Renal Tumour 1Meningitis 1Lung Diseases 1Intraoperative Complications 1Cerebrospinal Fluid Leak 1Cerebral Ventricle Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Thrombin × Clear all
NCT05717335 2023-02-08

Observational Pilot Study With TachoSil as a Ventricular Sealant

Germans Trias i Pujol Hospital

Completed
20 enrolled

Cerebral Ventricle Neoplasms, Meningitis, Cerebrospinal Fluid Leak

NCT00241163 2012-08-03

TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)

Takeda

Phase 3 Completed
170 enrolled

Surgical Resection of Superficial Renal Tumour

NCT00293514 2012-05-07

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Nycomed

Phase 3 Completed

Intraoperative Complications, Lung Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡